SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-24-025365
Filing Date
2024-06-27
Accepted
2024-06-27 07:22:46
Documents
15
Period of Report
2024-06-25
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 44786
2 ex3-1.htm EX-3.1 127332
  Complete submission text file 0001493152-24-025365.txt   375941

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE fblg-20240625.xsd EX-101.SCH 3033
4 XBRL LABEL FILE fblg-20240625_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE fblg-20240625_pre.xml EX-101.PRE 22371
18 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3927
Mailing Address 455 E. MEDICAL CENTER BLVD SUITE 300 SUITE 300 HOUSTON TX 77598
Business Address 455 E. MEDICAL CENTER BLVD SUITE 300 HOUSTON TX 77598 281-671-5152
FibroBiologics, Inc. (Filer) CIK: 0001958777 (see all company filings)

IRS No.: 863329066 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41934 | Film No.: 241075374
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)